✦ LIBER ✦

Evidence against involvement of p53 polymorphism in breast cancer predisposition

✍ Scribed by Evgeny N. Suspitsin; Konstantin G. Buslov; Maxim Yu. Grigoriev; Julia G. Ishutkina; Julia M. Ulibina; Victoria M. Gorodinskaya; Kazymir M. Pozharisski; Lev M. Berstein; Kaido P. Hanson; Alexandr V. Togo; Evgeny N. Imyanitov

Publisher: John Wiley and Sons
Year: 2002
Tongue: French
Weight: 52 KB
Volume: 103
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.10834

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Little evidence for involvement of MLH3

Little evidence for involvement of MLH3 in colorectal cancer predisposition

✍ Tuija Hienonen; Päivi Laiho; Reijo Salovaara; Jukka-Pekka Mecklin; Heikki Järvin 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 97 KB

## Abstract Mutations in the DNA MMR genes __MSH2__, __MLH1__, __MSH6__ and __PMS2__ underlie a large subset of HNPCC cases, and a hallmark of the tumors is MSI. In many HNPCC families, however, a causative mutation has not been found. Therefore, the involvement of additional, thus far unknown, gen

Polymorphisms in drug metabolism genes,

Polymorphisms in drug metabolism genes, smoking, and p53 mutations in breast cancer

✍ Beth O. Van Emburgh; Jennifer J. Hu; Edward A. Levine; Libyadda J. Mosley; L. Do 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

## Abstract Polymorphisms in phase I and phase II enzymes may enhance the occurrence of mutations at critical tumor suppressor genes, such as __p53__, and increase breast cancer risk by either increasing the activation or detoxification of carcinogens and/or endogenous estrogens. We analyzed polymo

Evidence of chromosome regions and gene

Evidence of chromosome regions and gene involvement in inflammatory breast cancer

✍ Florence Lerebours; Philippe Bertheau; Ivan Bieche; Keltouma Driouch; Hugues de 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 77 KB

## Abstract Inflammatory breast cancer (IBC) is a rare but particularly aggressive form of primary breast cancer. In contrast to noninflammatory breast cancer (non IBC), the molecular alterations underlying IBC are poorly known. We postulated that the kind and frequency of these alterations might d

Involvement of p53 in oroxylin A-induced

Involvement of p53 in oroxylin A-induced apoptosis in cancer cells

✍ Rong Mu; Qi Qi; Hongyan Gu; Jia Wang; Yong Yang; Jingjing Rong; Wei Liu; Na Lu; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB

## Abstract Oroxylin A, a naturally occurring monoflavonoid extracted from __Scutellariae__ radix, exhibits anticancer activity and induces apoptosis in human hepatocellular carcinoma HepG2 cells according to our previous data. In this study, we investigate whether p53 is involved in oroxylin A‐tri

Evidence of a hereditary p53 syndrome in

Evidence of a hereditary p53 syndrome in cancer-prone families

📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 425 KB 👁 2 views

P53 mediated regulation of metallothione

P53 mediated regulation of metallothionein transcription in breast cancer cells

✍ Elena A. Ostrakhovitch; Per-Erik Olsson; Jonas von Hofsten; M. George Cherian 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB

## Abstract Recent studies have shown that only breast cancer epithelial cells with intact p53 can induce metallothionein (MT) synthesis after exposure to metals. In this study, the potential role of p53 on regulation of MT was investigated. Results demonstrate that zinc and copper increased metal